Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?3.22
 
WKN: A2N7B5 / Symbol: NGM / Name: NGM Biopharmaceuticals / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

NGM Biopharmaceuticals Inc Stock

With 0 Sell predictions and 1 Buy predictions the community sentiment towards the NGM Biopharmaceuticals Inc stock is not clear.
With a target price of 3 € there is potential for a 112.77% increase which would mean more than doubling the current price of 1.41 € for NGM Biopharmaceuticals Inc.
Our community identified positive and negative aspects for NGM Biopharmaceuticals Inc stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the NGM Biopharmaceuticals Inc stock. On the other hand our users think that "Return on equity" could be a problem in the future.

Pros and Cons of NGM Biopharmaceuticals Inc in the next few years

Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 125.60%
Target price 3.220
Change
Ends at 22.11.24

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target lowered by analysts at B. Riley from $7.00 to $3.50. They now have a "buy" rating on the stock.
Ratings data for NGM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -59.48%
Target price 5.434
Change
Ends at 03.05.24

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for NGM provided by MarketBeat
Show more